Robert Baffi insider trades

Open-market stock purchases and sales by Robert Baffi, Director at Neurogene Inc, from SEC Form 4 filings since Mar 10, 2010.

Recent trades

DateStockTradeValue
Feb 20, 2026NGNE Neurogene IncBought (not open market)—

Companies traded

  • NGNE Neurogene Inc: other filings, last Feb 20, 2026
  • CPMV Mosaic ImmunoEngineering Inc: other filings, last Feb 18, 2022
  • BMRN Biomarin Pharmaceutical Inc: 26 sales, last Mar 20, 2020
  • KBIO Kalobios Pharmaceuticals Inc: other filings, last Jul 10, 2015

Get free alerts when Robert Baffi files a new trade →